Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001819133-25-000003
Filing Date
2025-10-28
Accepted
2025-10-28 10:15:31
Documents
1
Effectiveness Date
2025-10-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11523
  Complete submission text file 0001819133-25-000003.txt   12849
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-562231 | Film No.: 251421946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)